Physician profile
Donald E Murray
NPI 1659374239
$11,625.17
in general payments reported to CMS, 2019-2025
54 companies · $1,922 in 2025
The $1,922 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,284 · 2020: $773 · 2021: $2,141 · 2022: $2,056 · 2023: $1,864 · 2024: $1,585 · 2025: $1,922.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,351 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,351.24 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,701.14 | 2021-2025 | |
| Lilly USA, LLC | $1,378.15 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Amgen INC. | $1,039.80 | 2019-2025 | Evenity, Otezla, Repatha |
| Astrazeneca Pharmaceuticals Lp | $967.00 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $945.02 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $499.89 | 2019-2025 | Arexvy, Trelegy Ellipta |
| Astellas Pharma US INC | $381.54 | 2019-2024 | Veozah |
| Corcept Therapeutics | $376.16 | 2023-2025 | Korlym |
| Amarin Pharma, INC. | $375.01 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $329.01 | 2019-2022 | |
| Abbott Laboratories | $306.28 | 2023-2025 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $283.53 | 2019-2024 | Xifaxan |
| Nestle Healthcare Nutrition INC. | $272.08 | 2021-2023 | |
| Lundbeck LLC | $255.20 | 2022-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $228.69 | 2020-2024 | Xarelto, Spravato |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.